
Jakafi XR Wins FDA Approval for Myelofibrosis, Polycythemia Vera, and GVHD Treatment
Incyte Secures FDA Approval for Jakafi XR™ (Ruxolitinib Extended-Release), Expanding Treatment Options for Patients with Blood Disorders and GVHD Incyte has announced that the U.S. Food and Drug Administration has…












